Signed agreement for the Clinical Trial of BNCT with National Cancer Center, STELLA ...

Sumitomo Heavy Industries, Ltd. signed an agreement with National Cancer Center Japan, STELLA PHARMA CORPORATION, and Cancer Intelligence Care Systems, Inc. for Phase-I/II basket trials of the boron neutron capture therapy system (BNCT) for unresectable and recurrent thoracic malignant solid tumors. This is the first BNCT clinical trial covering several types of thoracic cancer, aiming to shorten development periods and offer optimal therapy options through FBPA-PET imaging before treatment.